Comparison of Two Treatment Strategies in Hypertensive Patients
Phase 4
Completed
- Conditions
- Hypertension
- Registration Number
- NCT00171444
- Lead Sponsor
- Novartis
- Brief Summary
The purpose of the study is to determine whether a specific training of General Practitioners (Family Physicians) regarding the new official guidelines for the treatment of hypertension results in a higher control of high Blood pressure in their patient population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4445
Inclusion Criteria
-
• Male or female patients >18 years of age
- Hypertension defined by MSDBP ≥ 90 and /or MSSBP ≥ 140 mmHg for untreated patients, patients on diet and exercise, patients on current anti-hypertensive monotherapy or bitherapy treatment who remain uncontrolled or patients experiencing unacceptable side-effects,
Exclusion Criteria
-
• Severe hypertension, secondary hypertension, type 1 diabetes mellitus
- History of congestive heart failure, unstable coronary insufficiency, life threatening arrhythmia, significant valvular disease, second or third degree heart block etc.
- Other protocol-defined exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Blood pressure less than 140/90 mmHg in non-diabetic patients, or less than 130/80 mmHg in patients with diabetes or kidney disease, after 8 weeks
- Secondary Outcome Measures
Name Time Method Change from baseline systolic blood pressure after 8 weeks Change from baseline diastolic blood pressure after 8 weeks Diastolic blood pressure less than 90 mmHg or reduction in diastolic blood pressure greater than 10 mmHg Systolic blood pressure less than 140 mmHg or reduction in diastolic blood pressure greater than 15 mmHg